RxDoctor Payments Data

Dwan Perry, DO

Sports Medicine · Lexington, KYNPI 1639304942

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,483 of the $4,467 with a category attached, or 78.0%. 8 manufacturers reported payments, led by AbbVie at 59.9% of the total. Reporting peaked in 2023 at $1,544 and has fallen 53.8% since, to $713 in 2025.

$4,467in general payments, 2019–2025

Across 195 payments — averaging $22.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Pacira Pharmaceuticals Incorporated$1K
  • SPR Therapeutics, Inc$419
  • Medtronic$148
  • Amneal Pharmaceuticals LLC$72
  • Avanir Pharmaceuticals, Inc.$39
  • plus $45 from 2 others

What the payments were for

  • Travel & lodging$98422%
  • Food & beverage$3,48378%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)177$2,676
Pacira Pharmaceuticals Incorporated5$1,070
SPR Therapeutics, Inc5$419
Medtronic1$148
Amneal Pharmaceuticals LLC3$72
Avanir Pharmaceuticals, Inc.2$39
Piramal Critical Care1$34
Coloplast1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,467 in reported general payments places this provider in the 75th percentile of 59 sports medicine providers in Kentucky.

See all sports medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$29,423
Medicare patients
162
Services billed
384

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium22$291
Naproxen20$150
Meloxicam32$102

Paid to pharmacies, not to this prescriber.

Other sports medicine in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →